United States Pharmaceuticals

Petlife Pharmaceuticals Inc (PTLF)

Track

Track

Ticker: PTLF Exchange: OTC
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
No insider activity signals detected

Insider trades have not triggered unusual activity signals for this company.

Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Campbell Vyvyan
Transaction date
Purchase
Price
458.63
Quantity 78,929 -45.5%
Value US$4,278,814
Campbell Vyvyan Large shareholder
Transaction date
Purchase
Price
276.30
Quantity 35,023 -38.5%
Value US$934,446
Campbell Vyvyan Large shareholder
Transaction date
Purchase
Price
445.15
Quantity 68,037 +13.9%
Value US$2,916,489
Salvagno Ralph T CEO Executive Director Large shareholder
Transaction date
Purchase
Price
0.64
Quantity 250,000 +28.1%
Value US$160,000
Salvagno Ralph T CEO Executive Director Large shareholder
Transaction date
Purchase
Price
0.46
Quantity 540,000 +154.3%
Value US$248,400
Salvagno Ralph T CEO Executive Director Large shareholder
Transaction date
Purchase
Price
0.64
Quantity 250,000 +250.0%
Value US$160,000
Salvagno Ralph T CEO Executive Director Large shareholder
Transaction date
Purchase
Price
0.25
Quantity 100,000 +inf%
Value US$25,000
Campbell Vyvyan Large shareholder
Transaction date
Purchase
Price
0.25
Quantity 100,000 +199.2%
Value US$25,000
Campbell Vyvyan Large shareholder
Transaction date
Purchase
Price
0.75
Quantity 50,210 +inf%
Value US$37,658
WHITE CURT C Former 10%/Officer/Director
Transaction date
Sale
Price
0.00
Quantity 13,000,000 -94.5%
Value US$5,200
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2018-03-20 2018-02-28 B Purchase Campbell Vyvyan
78,929 -45.5%
458.63
US$4,278,814 		78,929 -45.5% 458.63 US$4,278,814
2017-03-24 2017-02-23 B Purchase Campbell Vyvyan Large shareholder
35,023 -38.5%
276.30
US$934,446 		35,023 -38.5% 276.30 US$934,446
2017-03-24 2016-05-15 B Purchase Campbell Vyvyan Large shareholder
68,037 +13.9%
445.15
US$2,916,489 		68,037 +13.9% 445.15 US$2,916,489
2017-03-27 2016-02-12 B Purchase Salvagno Ralph T

CEO

Executive Director Large shareholder
250,000 +28.1%
0.64
US$160,000 		250,000 +28.1% 0.64 US$160,000
2017-03-27 2016-02-12 B Purchase Salvagno Ralph T

CEO

Executive Director Large shareholder
540,000 +154.3%
0.46
US$248,400 		540,000 +154.3% 0.46 US$248,400
2017-03-27 2016-02-12 B Purchase Salvagno Ralph T

CEO

Executive Director Large shareholder
250,000 +250.0%
0.64
US$160,000 		250,000 +250.0% 0.64 US$160,000
2017-03-27 2015-12-29 B Purchase Salvagno Ralph T

CEO

Executive Director Large shareholder
100,000 +inf%
0.25
US$25,000 		100,000 +inf% 0.25 US$25,000
2017-03-24 2015-11-09 B Purchase Campbell Vyvyan Large shareholder
100,000 +199.2%
0.25
US$25,000 		100,000 +199.2% 0.25 US$25,000
2017-03-24 2015-05-30 B Purchase Campbell Vyvyan Large shareholder
50,210 +inf%
0.75
US$37,658 		50,210 +inf% 0.75 US$37,658
2007-12-18 2007-12-13 S Sale WHITE CURT C

Former 10%/Officer/Director
13,000,000 -94.5%
0.00
US$5,200 		13,000,000 -94.5% 0.00 US$5,200
Explore more

More insider trading research around Petlife Pharmaceuticals Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America